343 related articles for article (PubMed ID: 29450258)
1. The Cannabinoids Δ
Thapa D; Cairns EA; Szczesniak AM; Toguri JT; Caldwell MD; Kelly MEM
Cannabis Cannabinoid Res; 2018; 3(1):11-20. PubMed ID: 29450258
[No Abstract] [Full Text] [Related]
2. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Thapa D; Cairns EA; Szczesniak AM; Kulkarni PM; Straiker AJ; Thakur GA; Kelly MEM
Molecules; 2020 Jan; 25(2):. PubMed ID: 31968549
[TBL] [Abstract][Full Text] [Related]
3. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
[TBL] [Abstract][Full Text] [Related]
4. Effect of cannabidiolic acid and ∆
Rock EM; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
6. Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease.
Tran BN; Maass M; Musial G; Stern ME; Gehlsen U; Steven P
Ocul Surf; 2022 Jan; 23():131-139. PubMed ID: 34922011
[TBL] [Abstract][Full Text] [Related]
7. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB
González-Mariscal I; Carmona-Hidalgo B; Winkler M; Unciti-Broceta JD; Escamilla A; Gómez-Cañas M; Fernández-Ruiz J; Fiebich BL; Romero-Zerbo SY; Bermúdez-Silva FJ; Collado JA; Muñoz E
Pharmacol Res; 2021 Jul; 169():105492. PubMed ID: 34019978
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
10. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
11. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
12. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer.
Afrin F; Chi M; Eamens AL; Duchatel RJ; Douglas AM; Schneider J; Gedye C; Woldu AS; Dun MD
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340151
[TBL] [Abstract][Full Text] [Related]
13.
Cherry AL; Wheeler MJ; Mathisova K; Di Miceli M
Front Neuroinform; 2024; 18():1294939. PubMed ID: 38404644
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol and Tetrahydrocannabinol Antinociceptive Activity is Mediated by Distinct Receptors in Caenorhabditis elegans.
Boujenoui F; Nkambeu B; Salem JB; Castano Uruena JD; Beaudry F
Neurochem Res; 2024 Apr; 49(4):935-948. PubMed ID: 38141130
[TBL] [Abstract][Full Text] [Related]
15. A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space.
Benredjem B; Pineyro G
Front Pharmacol; 2023; 14():1235255. PubMed ID: 37745077
[No Abstract] [Full Text] [Related]
16. Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.
Scuteri D; Rombolà L; Hamamura K; Sakurada T; Watanabe C; Sakurada S; Guida F; Boccella S; Maione S; Gallo Afflitto G; Nucci C; Tonin P; Bagetta G; Corasaniti MT
Biomed Pharmacother; 2022 Feb; 146():112505. PubMed ID: 34891121
[TBL] [Abstract][Full Text] [Related]
17. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined doses of Δ
Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain.
Henderson-Redmond AN; Crawford LC; Sepulveda DE; Hale DE; Lesperance JJ; Morgan DJ
Front Mol Biosci; 2021; 8():684115. PubMed ID: 34250019
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids and Pain: Sites and Mechanisms of Action.
Starowicz K; Finn DP
Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
